Literature DB >> 17674683

Botulinum toxin (Botox) to enhance facial macroesthetics: a literature review.

Sarosh F Dastoor1, Carl E Misch, Hom-Lay Wang.   

Abstract

Dental implants have emerged as a predictable treatment option for partial edentulism. Their ability to preserve bone and soft tissue yields highly esthetic results in the long term. Increasingly, patients are demanding not only enhancements to their dental (micro) esthetics but also to their overall facial (macro) esthetics. Dynamic wrinkles (caused by hyperfunctional muscles) in the perioral, glabellar, and forehead regions can cause a patient's expressions to be misinterpreted as angry, anxious, fearful, or fatigued. An emerging treatment option to address these issues is the use of a paralyzing material such as botulinum toxin A (Botox) to decrease the appearance of the wrinkles, which yields a more esthetic and youthful facial appearance. Botox is a deadly poison that is produced by the bacterium Clostridium botulinum and causes muscle paralysis by inhibiting acetylcholine release at the neuromuscular junction. When used in areas of hyperfunctional muscles, a transient partial paralysis occurs that diminishes the appearances of wrinkles, Therefore, wrinkles not attributable to hyperfunctional muscles (e.g., wrinkles caused by aging, gravity, photodamage, trauma, and scarring) will not be amenable to treatment with the toxin. As a result, proper case selection is essential. A thorough understanding of the indications, techniques, dosages, and complications and their management is imperative to achieve a satisfactory result. This article will review the pathogenesis of facial wrinkles as well as the history, techniques, clinical controversies, and other important considerations for successful treatment of facial wrinkles with Botox.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17674683     DOI: 10.1563/0-835.1

Source DB:  PubMed          Journal:  J Oral Implantol        ISSN: 0160-6972            Impact factor:   1.779


  8 in total

1.  Molecular basis of activation of endopeptidase activity of botulinum neurotoxin type E.

Authors:  Roshan V Kukreja; Shashi K Sharma; Bal Ram Singh
Journal:  Biochemistry       Date:  2010-03-23       Impact factor: 3.162

2.  An Evaluation of Use of Botulinum Toxin Type A in the Management of Dynamic Forehead Wrinkles - A Clinical Study.

Authors:  Avvaru Susmita; Naga Neelima Devi Kolli; Sridhar Meka; Srinivas Pandi Chakravarthi; Vivekanand Sabanna Kattimani; Krishna Prasad Lingamaneni; Latheef Saheb Shaik
Journal:  J Clin Diagn Res       Date:  2016-10-01

Review 3.  Toxins from bacteria.

Authors:  James S Henkel; Michael R Baldwin; Joseph T Barbieri
Journal:  EXS       Date:  2010

Review 4.  The use of botulinum toxin in head and face medicine: an interdisciplinary field.

Authors:  Rainer Laskawi
Journal:  Head Face Med       Date:  2008-03-10       Impact factor: 2.151

5.  Efficacy of Botox versus Placebo for Treatment of Patients with Major Depression.

Authors:  Abbas Zamanian; Atefeh Ghanbari Jolfaei; Golnaz Mehran; Zahra Azizian
Journal:  Iran J Public Health       Date:  2017-07       Impact factor: 1.429

Review 6.  Botox and Dermal Fillers in Orthodontics - A Review.

Authors:  Truppti Pavinvhandra Sonone; Vivek Soni; Soumya Gupta; Yash K Shekatkar; Aniket S Thorat; Tejas R Pol
Journal:  J Pharm Bioallied Sci       Date:  2022-07-13

Review 7.  Botox Therapy in Dentistry: A Review.

Authors:  Aftab Azam; Sunny Manchanda; Suman Thotapalli; Sunil Babu Kotha
Journal:  J Int Oral Health       Date:  2015

Review 8.  Botulinum Toxin Application in Facial Esthetics and Recent Treatment Indications (2013-2018).

Authors:  Vivekanand Kattimani; Rahul Vinay Chandra Tiwari; Khalid Gufran; Bharti Wasan; P H Shilpa; Anas Abdul Khader
Journal:  J Int Soc Prev Community Dent       Date:  2019-04-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.